NivolumabSecondary sclerosing cholangitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1770卷 / 1期

关键词：

D O I：

10.1007/s40278-019-67746-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：311 / 311

相关论文

共 50 条

[1] NivolumabSecondary sclerosing cholangitis: case report
Reactions Weekly, 2019, 1737 (1) : 217 - 217
[2] Immunosuppressants/nivolumabSecondary sclerosing cholangitis and lack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 242 - 242
[3] PembrolizumabSecondary sclerosing cholangitis: case report
Reactions Weekly, 2019, 1741 (1) : 192 - 192
[4] PembrolizumabSecondary sclerosing cholangitis: case report
Reactions Weekly, 2022, 1887 (1) : 571 - 571
[5] PaclitaxelSecondary sclerosing cholangitis: case report
Reactions Weekly, 2016, 1586 (1) : 231 - 231
[6] PembrolizumabSecondary sclerosing cholangitis: case report
Reactions Weekly, 2021, 1884 (1) : 357 - 357
[7] RisperidoneSecondary sclerosing cholangitis: case report
Reactions Weekly, 2021, 1836 (1) : 685 - 685
[8] PembrolizumabSecondary sclerosing cholangitis: case report
Reactions Weekly, 2020, 1810 (1) : 173 - 173
[9] PembrolizumabBronchiolitis and sclerosing cholangitis: case report
Reactions Weekly, 2023, 1972 (1) : 291 - 291
[10] Primary sclerosing cholangitis - A case report
Wolbrink, A
AVIATION SPACE AND ENVIRONMENTAL MEDICINE, 2000, 71 (01): : 83 - 84

← 1 2 3 4 5 →